Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10013412HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013413HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013414HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013415HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013416HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013417HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013418HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013419HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10013420HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS10019801HBVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB01625
Drug NameIsopropamide
Target IDBE0000045
UniProt IDP20309
Regulation Typeantagonist
PubMed IDs3580704; 29133
CitationsEglen RM, Whiting RL: Competitive and non-competitive antagonism exhibited by 'selective' antagonists at atrial and ileal muscarinic receptor subtypes. Br J Pharmacol. 1987 Apr;90(4):701-7.@@Lane MA: Muscarinic cholinergic activation of mouse spleen cells cytotoxic to tumor cells in vitro. J Natl Cancer Inst. 1978 Sep;61(3):923-6.
GroupsApproved; Vet_approved
Direct ClassificationDiphenylmethanes
SMILESCC(C)[N+](C)(CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1)C(C)C
Pathways
PharmGKBPA164781398
ChEMBLCHEMBL1201232